Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity.
Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity.
复制标题
DOI:
10.1038/nmicrobiol.2016.164
复制
发表时间:
2016-09-19
影响因子:
28.3
通讯作者:
Ooi EE
中科院分区:
文献类型:
--
作者:
Chan KR;Wang X;Saron WAA;Gan ES;Tan HC;Mok DZL;Zhang SL;Lee YH;Liang C;Wijaya L;Ghosh S;Cheung YB;Tannenbaum SR;Abraham SN;St John AL;Low JGH;Ooi EE
Vaccination has achieved remarkable successes in the control of childhood viral diseases. To control emerging infections, however, vaccines will need to be delivered to older individuals who, unlike infants, probably have had prior infection or vaccination with related viruses and thus have cross-reactive antibodies against the vaccines. Whether and how these cross-reactive antibodies impact live attenuated vaccination efficacy is unclear. Using an open-label randomized trial design, we show that subjects with a specific range of cross-reactive antibody titres from a prior inactivated Japanese encephalitis vaccination enhanced yellow fever (YF) immunogenicity upon YF vaccination. Enhancing titres of cross-reactive antibodies prolonged YF vaccine viraemia, provoked greater pro-inflammatory responses, and induced adhesion molecules intrinsic to the activating Fc-receptor signalling pathway, namely immune semaphorins, facilitating immune cell interactions and trafficking. Our findings clinically demonstrate antibody-enhanced infection and suggest that vaccine efficacy could be improved by exploiting cross-reactive antibodies. The online version of this article (doi:10.1038/nmicrobiol.2016.164) contains supplementary material, which is available to authorized users. Immunization with inactivated Japanese encephalitis vaccine generates cross-reactive antibodies that enhance immunogenicity on subsequent immunization with live attenuated yellow fever vaccine, demonstrating antibody-dependent enhancement of infection in a clinical trial. The online version of this article (doi:10.1038/nmicrobiol.2016.164) contains supplementary material, which is available to authorized users.
登录
查看更多内容
DOI:
10.1056/nejmoa1411100
发表时间:
2014-10-16
期刊:
The New England journal of medicine
影响因子:
--
作者:
WHO Ebola Response Team;Aylward B;Barboza P;Bawo L;Bertherat E;Bilivogui P;Blake I;Brennan R;Briand S;Chakauya JM;Chitala K;Conteh RM;Cori A;Croisier A;Dangou JM;Diallo B;Donnelly CA;Dye C;Eckmanns T;Ferguson NM;Formenty P;Fuhrer C;Fukuda K;Garske T;Gasasira A;Gbanyan S;Graaff P;Heleze E;Jambai A;Jombart T;Kasolo F;Kadiobo AM;Keita S;Kertesz D;Koné M;Lane C;Markoff J;Massaquoi M;Mills H;Mulba JM;Musa E;Myhre J;Nasidi A;Nilles E;Nouvellet P;Nshimirimana D;Nuttall I;Nyenswah T;Olu O;Pendergast S;Perea W;Polonsky J;Riley S;Ronveaux O;Sakoba K;Santhana Gopala Krishnan R;Senga M;Shuaib F;Van Kerkhove MD;Vaz R;Wijekoon Kannangarage N;Yoti Z
通讯作者:
Yoti Z
影响因子:
5.4
作者:
Boonnak, Kobporn;Dambach, Kaitlyn M.;Marovich, Mary A.
通讯作者:
Marovich, Mary A.
影响因子:
158.5
作者:
Hadinegoro, S. R.;Arredondo-Garcia, J. L.;Saville, M.
通讯作者:
Saville, M.
影响因子:
168.9
作者:
Buchbinder, Susan P.;Mehrotra, Devon V.;Duerr, Ann;Fitzgerald, Daniel W.;Mogg, Robin;Li, David;Gilbert, Peter B.;Lama, Javier R.;Marmor, Michael;del Rio, Carlos;McElrath, M. Juliana;Casimiro, Danilo R.;Gottesdiener, Keith M.;Chodakewitz, Jeffrey A.;Corey, Lawrence;Robertson, Michael N.
通讯作者:
Robertson, Michael N.
影响因子:
5.8
作者:
Hanson BJ;Boon AC;Lim AP;Webb A;Ooi EE;Webby RJ
通讯作者:
Webby RJ